On Friday, iRhythm Technologies Inc (NASDAQ: IRTC) opened lower -5.19% from the last session, before settling in for the closing price of $189.25. Price fluctuations for IRTC have ranged from $86.99 to $212.00 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -10.95%. Company’s average yearly earnings per share was noted 58.54% at the time writing. With a float of $31.69 million, this company’s outstanding shares have now reached $32.20 million.
iRhythm Technologies Inc (IRTC) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of iRhythm Technologies Inc is 1.63%, while institutional ownership is 109.15%. The most recent insider transaction that took place on Dec 02 ’25, was worth 51,752. In this transaction CHIEF COMM & PRODUCT OFFICER of this company sold 280 shares at a rate of $184.83, taking the stock ownership to the 43,387 shares. Before that another transaction happened on Dec 02 ’25, when Company’s CBO and CLO sold 2,478 for $184.83, making the entire transaction worth $458,009. This insider now owns 53,281 shares in total.
iRhythm Technologies Inc (IRTC) Recent Fiscal highlights
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted 0.01 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.24) by 0.25. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.53 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 58.54% per share during the next fiscal year.
iRhythm Technologies Inc (NASDAQ: IRTC) Trading Performance Indicators
Check out the current performance indicators for iRhythm Technologies Inc (IRTC). In the past quarter, the stock posted a quick ratio of 4.50. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.68. Likewise, its price to free cash flow for the trailing twelve months is 188.08.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.62, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach -0.52 in one year’s time.
